#biomarker — Friday, October 16, 2026 (2 items)
| 12 | ℹ |
EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-10-16 | #clinical trial #immunotherapy #glioma #targeted therapy #biomarker | |
| 2 | ℹ |
BUB signaling in cancer and molecular insights into targeted therapies.
(nature.com)
|
Communications Biology 2026-10-16 | #cancer #cell cycle #targeted therapy #chromosomal instability #biomarker |